An update on the current status and future prospects of erectile dysfunction following radical prostatectomy
Background Radical prostatectomy (RP) and radiation treatment are standard options for localized prostate cancer. Even though nerve‐sparing techniques have been increasingly utilized in RP, erectile dysfunction (ED) due to neuropraxia remains a frequent complication. Erectile function recovery rates...
Gespeichert in:
Veröffentlicht in: | The Prostate 2022-09, Vol.82 (12), p.1135-1161 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1161 |
---|---|
container_issue | 12 |
container_start_page | 1135 |
container_title | The Prostate |
container_volume | 82 |
creator | Asker, Heba Yilmaz‐Oral, Didem Oztekin, Cetin Volkan Gur, Serap |
description | Background
Radical prostatectomy (RP) and radiation treatment are standard options for localized prostate cancer. Even though nerve‐sparing techniques have been increasingly utilized in RP, erectile dysfunction (ED) due to neuropraxia remains a frequent complication. Erectile function recovery rates after RP remain unsatisfactory, and many men still suffer despite the availability of various therapies.
Objective
This systematic review aims to summarize the current treatments for post‐RP‐ED, assess the underlying pathological mechanisms, and emphasize promising therapeutic strategies based on the evidence from basic research.
Method
Evaluation and review of articles on the relevant topic published between 2010 and 2021, which are indexed and listed in the PubMed database.
Results
Phosphodiesterase type 5 inhibitors, intracavernosal and intraurethral injections, vacuum erection devices, pelvic muscle training, and surgical procedures are utilized for penile rehabilitation. Clinical trials evaluating the efficacy of erectogenic drugs in this setting are conflicting and far from being conclusive. The use of androgen deprivation therapy in certain scenarios after RP further exacerbates the already problematic situation and emphasizes the need for effective treatment strategies.
Conclusion
This article is a detailed overview focusing on the pathophysiology and mechanism of the nerve injury developed during RP and a compilation of various strategies to induce cavernous nerve regeneration to improve erectile function (EF). These strategies include stem cell therapy, gene therapy, growth factors, low‐intensity extracorporeal shockwave therapy, immunophilins, and various pharmacological approaches that have induced improvements in EF in experimental models of cavernous nerve injury. Many of the mentioned strategies can improve EF following RP if transformed into clinically applicable safe, and effective techniques with reproducible outcomes. |
doi_str_mv | 10.1002/pros.24366 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2665562960</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2693571096</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3576-9381a01345cac9bca481e4503808164c2507d11bafaec24b4ec5f15d402c05f23</originalsourceid><addsrcrecordid>eNp9kUlPwzAQhS0EgrJc-AHIEheElDJe0xyrik1CArGcI9exIShNih2r6r9nusCBA6eZwzdv5r0h5JTBkAHwq3no4pBLofUOGTAo8gxAql0yAJ5DJpnID8hhjJ8AiAPfJwdCqbwAJQakGbc0zSvTO9q1tP9w1KYQXNvT2Js-RWraivrUp-Doas_c2T7SzlMXsKsbR6tl9KnFHud91zTdom7faTBVbU2znkEhZLvZ8pjsedNEd7KtR-Tt5vp1cpc9PN7eT8YPmRUq11khRswAE1JZY4upNXLEnFQgRjBiWlquIK8YmxpvnOVyKp1VnqlKAregPBdH5GKji9u_kot9OaujdU1jWtelWHKtldK80IDo-R_0s0uhxeuQKvAczFMjdbmhLNqJwflyHuqZCcuSQbn6QbnyWa5_gPDZVjJNZ676RX9CR4BtgAXmt_xHqnx6fnzZiH4DSWmSyw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2693571096</pqid></control><display><type>article</type><title>An update on the current status and future prospects of erectile dysfunction following radical prostatectomy</title><source>Wiley Online Library All Journals</source><creator>Asker, Heba ; Yilmaz‐Oral, Didem ; Oztekin, Cetin Volkan ; Gur, Serap</creator><creatorcontrib>Asker, Heba ; Yilmaz‐Oral, Didem ; Oztekin, Cetin Volkan ; Gur, Serap</creatorcontrib><description>Background
Radical prostatectomy (RP) and radiation treatment are standard options for localized prostate cancer. Even though nerve‐sparing techniques have been increasingly utilized in RP, erectile dysfunction (ED) due to neuropraxia remains a frequent complication. Erectile function recovery rates after RP remain unsatisfactory, and many men still suffer despite the availability of various therapies.
Objective
This systematic review aims to summarize the current treatments for post‐RP‐ED, assess the underlying pathological mechanisms, and emphasize promising therapeutic strategies based on the evidence from basic research.
Method
Evaluation and review of articles on the relevant topic published between 2010 and 2021, which are indexed and listed in the PubMed database.
Results
Phosphodiesterase type 5 inhibitors, intracavernosal and intraurethral injections, vacuum erection devices, pelvic muscle training, and surgical procedures are utilized for penile rehabilitation. Clinical trials evaluating the efficacy of erectogenic drugs in this setting are conflicting and far from being conclusive. The use of androgen deprivation therapy in certain scenarios after RP further exacerbates the already problematic situation and emphasizes the need for effective treatment strategies.
Conclusion
This article is a detailed overview focusing on the pathophysiology and mechanism of the nerve injury developed during RP and a compilation of various strategies to induce cavernous nerve regeneration to improve erectile function (EF). These strategies include stem cell therapy, gene therapy, growth factors, low‐intensity extracorporeal shockwave therapy, immunophilins, and various pharmacological approaches that have induced improvements in EF in experimental models of cavernous nerve injury. Many of the mentioned strategies can improve EF following RP if transformed into clinically applicable safe, and effective techniques with reproducible outcomes.</description><identifier>ISSN: 0270-4137</identifier><identifier>EISSN: 1097-0045</identifier><identifier>DOI: 10.1002/pros.24366</identifier><identifier>PMID: 35579053</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Cancer surgery ; cavernous nerve injury ; Cell therapy ; Clinical trials ; Erectile dysfunction ; Gene therapy ; Growth factors ; Immunophilins ; Penis ; Phosphodiesterase ; phosphodiesterase type 5 inhibitors ; Prostate cancer ; Prostatectomy ; radical prostatectomy ; Regeneration ; Rehabilitation ; stem cell therapy ; Stem cells ; Urological surgery</subject><ispartof>The Prostate, 2022-09, Vol.82 (12), p.1135-1161</ispartof><rights>2022 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3576-9381a01345cac9bca481e4503808164c2507d11bafaec24b4ec5f15d402c05f23</citedby><cites>FETCH-LOGICAL-c3576-9381a01345cac9bca481e4503808164c2507d11bafaec24b4ec5f15d402c05f23</cites><orcidid>0000-0003-2057-3781 ; 0000-0002-9515-0698 ; 0000-0003-2082-2135 ; 0000-0002-1730-7282</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpros.24366$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpros.24366$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35579053$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Asker, Heba</creatorcontrib><creatorcontrib>Yilmaz‐Oral, Didem</creatorcontrib><creatorcontrib>Oztekin, Cetin Volkan</creatorcontrib><creatorcontrib>Gur, Serap</creatorcontrib><title>An update on the current status and future prospects of erectile dysfunction following radical prostatectomy</title><title>The Prostate</title><addtitle>Prostate</addtitle><description>Background
Radical prostatectomy (RP) and radiation treatment are standard options for localized prostate cancer. Even though nerve‐sparing techniques have been increasingly utilized in RP, erectile dysfunction (ED) due to neuropraxia remains a frequent complication. Erectile function recovery rates after RP remain unsatisfactory, and many men still suffer despite the availability of various therapies.
Objective
This systematic review aims to summarize the current treatments for post‐RP‐ED, assess the underlying pathological mechanisms, and emphasize promising therapeutic strategies based on the evidence from basic research.
Method
Evaluation and review of articles on the relevant topic published between 2010 and 2021, which are indexed and listed in the PubMed database.
Results
Phosphodiesterase type 5 inhibitors, intracavernosal and intraurethral injections, vacuum erection devices, pelvic muscle training, and surgical procedures are utilized for penile rehabilitation. Clinical trials evaluating the efficacy of erectogenic drugs in this setting are conflicting and far from being conclusive. The use of androgen deprivation therapy in certain scenarios after RP further exacerbates the already problematic situation and emphasizes the need for effective treatment strategies.
Conclusion
This article is a detailed overview focusing on the pathophysiology and mechanism of the nerve injury developed during RP and a compilation of various strategies to induce cavernous nerve regeneration to improve erectile function (EF). These strategies include stem cell therapy, gene therapy, growth factors, low‐intensity extracorporeal shockwave therapy, immunophilins, and various pharmacological approaches that have induced improvements in EF in experimental models of cavernous nerve injury. Many of the mentioned strategies can improve EF following RP if transformed into clinically applicable safe, and effective techniques with reproducible outcomes.</description><subject>Cancer surgery</subject><subject>cavernous nerve injury</subject><subject>Cell therapy</subject><subject>Clinical trials</subject><subject>Erectile dysfunction</subject><subject>Gene therapy</subject><subject>Growth factors</subject><subject>Immunophilins</subject><subject>Penis</subject><subject>Phosphodiesterase</subject><subject>phosphodiesterase type 5 inhibitors</subject><subject>Prostate cancer</subject><subject>Prostatectomy</subject><subject>radical prostatectomy</subject><subject>Regeneration</subject><subject>Rehabilitation</subject><subject>stem cell therapy</subject><subject>Stem cells</subject><subject>Urological surgery</subject><issn>0270-4137</issn><issn>1097-0045</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kUlPwzAQhS0EgrJc-AHIEheElDJe0xyrik1CArGcI9exIShNih2r6r9nusCBA6eZwzdv5r0h5JTBkAHwq3no4pBLofUOGTAo8gxAql0yAJ5DJpnID8hhjJ8AiAPfJwdCqbwAJQakGbc0zSvTO9q1tP9w1KYQXNvT2Js-RWraivrUp-Doas_c2T7SzlMXsKsbR6tl9KnFHud91zTdom7faTBVbU2znkEhZLvZ8pjsedNEd7KtR-Tt5vp1cpc9PN7eT8YPmRUq11khRswAE1JZY4upNXLEnFQgRjBiWlquIK8YmxpvnOVyKp1VnqlKAregPBdH5GKji9u_kot9OaujdU1jWtelWHKtldK80IDo-R_0s0uhxeuQKvAczFMjdbmhLNqJwflyHuqZCcuSQbn6QbnyWa5_gPDZVjJNZ676RX9CR4BtgAXmt_xHqnx6fnzZiH4DSWmSyw</recordid><startdate>20220901</startdate><enddate>20220901</enddate><creator>Asker, Heba</creator><creator>Yilmaz‐Oral, Didem</creator><creator>Oztekin, Cetin Volkan</creator><creator>Gur, Serap</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TO</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2057-3781</orcidid><orcidid>https://orcid.org/0000-0002-9515-0698</orcidid><orcidid>https://orcid.org/0000-0003-2082-2135</orcidid><orcidid>https://orcid.org/0000-0002-1730-7282</orcidid></search><sort><creationdate>20220901</creationdate><title>An update on the current status and future prospects of erectile dysfunction following radical prostatectomy</title><author>Asker, Heba ; Yilmaz‐Oral, Didem ; Oztekin, Cetin Volkan ; Gur, Serap</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3576-9381a01345cac9bca481e4503808164c2507d11bafaec24b4ec5f15d402c05f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Cancer surgery</topic><topic>cavernous nerve injury</topic><topic>Cell therapy</topic><topic>Clinical trials</topic><topic>Erectile dysfunction</topic><topic>Gene therapy</topic><topic>Growth factors</topic><topic>Immunophilins</topic><topic>Penis</topic><topic>Phosphodiesterase</topic><topic>phosphodiesterase type 5 inhibitors</topic><topic>Prostate cancer</topic><topic>Prostatectomy</topic><topic>radical prostatectomy</topic><topic>Regeneration</topic><topic>Rehabilitation</topic><topic>stem cell therapy</topic><topic>Stem cells</topic><topic>Urological surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Asker, Heba</creatorcontrib><creatorcontrib>Yilmaz‐Oral, Didem</creatorcontrib><creatorcontrib>Oztekin, Cetin Volkan</creatorcontrib><creatorcontrib>Gur, Serap</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Prostate</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Asker, Heba</au><au>Yilmaz‐Oral, Didem</au><au>Oztekin, Cetin Volkan</au><au>Gur, Serap</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An update on the current status and future prospects of erectile dysfunction following radical prostatectomy</atitle><jtitle>The Prostate</jtitle><addtitle>Prostate</addtitle><date>2022-09-01</date><risdate>2022</risdate><volume>82</volume><issue>12</issue><spage>1135</spage><epage>1161</epage><pages>1135-1161</pages><issn>0270-4137</issn><eissn>1097-0045</eissn><abstract>Background
Radical prostatectomy (RP) and radiation treatment are standard options for localized prostate cancer. Even though nerve‐sparing techniques have been increasingly utilized in RP, erectile dysfunction (ED) due to neuropraxia remains a frequent complication. Erectile function recovery rates after RP remain unsatisfactory, and many men still suffer despite the availability of various therapies.
Objective
This systematic review aims to summarize the current treatments for post‐RP‐ED, assess the underlying pathological mechanisms, and emphasize promising therapeutic strategies based on the evidence from basic research.
Method
Evaluation and review of articles on the relevant topic published between 2010 and 2021, which are indexed and listed in the PubMed database.
Results
Phosphodiesterase type 5 inhibitors, intracavernosal and intraurethral injections, vacuum erection devices, pelvic muscle training, and surgical procedures are utilized for penile rehabilitation. Clinical trials evaluating the efficacy of erectogenic drugs in this setting are conflicting and far from being conclusive. The use of androgen deprivation therapy in certain scenarios after RP further exacerbates the already problematic situation and emphasizes the need for effective treatment strategies.
Conclusion
This article is a detailed overview focusing on the pathophysiology and mechanism of the nerve injury developed during RP and a compilation of various strategies to induce cavernous nerve regeneration to improve erectile function (EF). These strategies include stem cell therapy, gene therapy, growth factors, low‐intensity extracorporeal shockwave therapy, immunophilins, and various pharmacological approaches that have induced improvements in EF in experimental models of cavernous nerve injury. Many of the mentioned strategies can improve EF following RP if transformed into clinically applicable safe, and effective techniques with reproducible outcomes.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>35579053</pmid><doi>10.1002/pros.24366</doi><tpages>27</tpages><orcidid>https://orcid.org/0000-0003-2057-3781</orcidid><orcidid>https://orcid.org/0000-0002-9515-0698</orcidid><orcidid>https://orcid.org/0000-0003-2082-2135</orcidid><orcidid>https://orcid.org/0000-0002-1730-7282</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0270-4137 |
ispartof | The Prostate, 2022-09, Vol.82 (12), p.1135-1161 |
issn | 0270-4137 1097-0045 |
language | eng |
recordid | cdi_proquest_miscellaneous_2665562960 |
source | Wiley Online Library All Journals |
subjects | Cancer surgery cavernous nerve injury Cell therapy Clinical trials Erectile dysfunction Gene therapy Growth factors Immunophilins Penis Phosphodiesterase phosphodiesterase type 5 inhibitors Prostate cancer Prostatectomy radical prostatectomy Regeneration Rehabilitation stem cell therapy Stem cells Urological surgery |
title | An update on the current status and future prospects of erectile dysfunction following radical prostatectomy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T13%3A19%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20update%20on%20the%20current%20status%20and%20future%20prospects%20of%20erectile%20dysfunction%20following%20radical%20prostatectomy&rft.jtitle=The%20Prostate&rft.au=Asker,%20Heba&rft.date=2022-09-01&rft.volume=82&rft.issue=12&rft.spage=1135&rft.epage=1161&rft.pages=1135-1161&rft.issn=0270-4137&rft.eissn=1097-0045&rft_id=info:doi/10.1002/pros.24366&rft_dat=%3Cproquest_cross%3E2693571096%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2693571096&rft_id=info:pmid/35579053&rfr_iscdi=true |